+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Livestock Medicine Market by Product Type, Disease Type, Animal Type, Formulation, Route of Administration, End Users - Global Forecast 2025-2030- Product Image
Livestock Medicine Market by Product Type, Disease Type, Animal Type, Formulation, Route of Administration, End Users - Global Forecast 2025-2030- Product Image
Sale

Livestock Medicine Market by Product Type, Disease Type, Animal Type, Formulation, Route of Administration, End Users - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715776
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Livestock Medicine Market grew from USD 19.56 billion in 2024 to USD 20.56 billion in 2025. It is expected to continue growing at a CAGR of 5.27%, reaching USD 26.63 billion by 2030.

Livestock medicine is entering an era marked by rapid innovation, strategic realignments, and evolving market demands. Over the past few years, advancements in veterinary science, coupled with an increased focus on animal welfare and sustainable production practices, have created a new environment for stakeholders across the value chain. In this dynamic landscape, industry participants are not only investing heavily in research and development but are also rethinking traditional treatment paradigms. The integration of modern diagnostic technologies with time-tested therapeutic approaches has paved the way for more effective and targeted treatment protocols.

This transformation fuels growth and presents both challenges and opportunities. As regulatory frameworks evolve and consumer demands shift towards higher standards of animal care, there is an increasing need for robust data and actionable insights. The ongoing drive to optimize health outcomes and operational efficiency continues to reshape market strategies. In this report, we delve into the critical trends influencing the market and explore how strategic innovations are redefining livestock medicine. Crafted for decision-makers and industry experts alike, this analysis reflects the convergence of scientific advancement with market intelligence, laying the groundwork for informed strategic planning and sustainable growth.

Transformative Shifts in the Landscape

The livestock medicine industry is witnessing transformative shifts that are redefining traditional treatment models and aligning them with the demands of modern veterinary care. Emerging trends include the integration of digital technologies, enhanced biosecurity protocols, and the development of novel therapeutic solutions designed to address both common and complex health challenges. These shifts are not occurring in isolation but are driven by a confluence of technological innovation, evolving regulatory standards, and heightened consumer awareness.

Economic pressures, both at the production and supply chain levels, have spurred the adoption of precision medicine techniques, which offer targeted and efficient interventions. This focus on precision has been bolstered by real-time data analytics, enabling practitioners to tailor treatments based on individual animal responses and environmental conditions. Additionally, advances in genetics and bioengineering are fostering the emergence of innovative solutions that address age-old challenges such as infection control, resistance management, and overall herd immunity.

The market’s evolution is further accelerated by global collaborations and public-private partnerships, which are essential for bridging research and practical application. As stakeholders navigate this complex ecosystem, the need for agile strategies and proactive planning has never been clearer. The transformative shifts discussed here set the stage for a more responsive, efficient, and sustainable approach to livestock health management.

Key Segmentation Insights Across the Market Spectrum

A thorough understanding of market segmentation reveals critical insights that drive strategic decision-making in livestock medicine. The industry is dissected using various dimensions, starting with product types that include a range of anti-inflammatory agents, antibiotics, antiparasitic agents, feed additives, hormones, and vaccines. In-depth analysis further differentiates antibiotics by classifying them as cephalosporins, penicillins, and tetracyclines. In a similar vein, antiparasitic agents are understood through the lenses of ectoparasiticides and endoparasiticides, while feed additives are evaluated in terms of prebiotics and probiotics. Hormones too are segmented into growth hormones and reproductive hormones, and vaccines are categorized into inactivated, live attenuated, and subunit varieties.

Beyond product type, segmentation by disease type unpacks the complexities of management across infectious diseases, metabolic diseases, nutritional deficiency diseases, parasitic diseases, and reproductive diseases. When the focus shifts to animal types, the market analysis expands to include aquaculture, cattle, goats, poultry, sheep, and swine, each with unique treatment protocols and market dynamics. Further, analysis based on formulation showcases diversity through capsules, gels, liquids, powders, and tablets, while the route of administration is carefully examined by considering inhalation, injectable, oral, and topical options. The injectable route is nuanced into intramuscular and intravenous applications; similarly, oral formulas include both liquid and tablet forms, and topical administrations bring creams and patches into play.

Finally, insights based on end users offer a panoramic view of the market landscape by considering livestock farmers, veterinary clinics, and veterinary hospitals. This multi-tiered segmentation framework not only highlights the intricacies of the market but also underscores the importance of tailored strategies that cater to distinct subsegments. Such detailed segmentation aids in identifying untapped growth areas and optimizing resource allocation, ensuring that products and treatments are precisely aligned with the evolving needs of diverse user groups.

Based on Product Type, market is studied across Anti-inflammatory Agents, Antibiotics, Antiparasitic Agents, Feed Additives, Hormones, and Vaccines. The Antibiotics is further studied across Cephalosporins, Penicillins, and Tetracyclines. The Antiparasitic Agents is further studied across Ectoparasiticides and Endoparasiticides. The Feed Additives is further studied across Prebiotics and Probiotics. The Hormones is further studied across Growth Hormones and Reproductive Hormones. The Vaccines is further studied across Inactivated Vaccines, Live Attenuated Vaccines, and Subunit Vaccines.

Based on Disease Type, market is studied across Infectious Diseases, Metabolic Diseases, Nutritional Deficiency Diseases, Parasitic Diseases, and Reproductive Diseases.

Based on Animal Type, market is studied across Aquaculture, Cattle, Goats, Poultry, Sheep, and Swine.

Based on Formulation, market is studied across Capsules, Gels, Liquids, Powders, and Tablets.

Based on Route of Administration, market is studied across Inhalation, Injectable, Oral, and Topical. The Injectable is further studied across Intramuscular and Intravenous. The Oral is further studied across Liquids and Tablets. The Topical is further studied across Creams and Patches.

Based on End Users, market is studied across Livestock Farmers, Veterinary Clinics, and Veterinary Hospitals.

Key Regional Insights Driving Market Evolution

Regional dynamics play a pivotal role in shaping the trajectory of livestock medicine across the globe. Market analysis reveals distinct trends and opportunities across diverse geographies. In the Americas, the focus remains on integrating advanced diagnostic techniques and promoting high-quality treatment protocols, which is vital to meeting strict regulatory standards and addressing pressing issues related to animal health. The market here is bolstered by extensive research investments and a robust veterinary infrastructure that supports rapid adoption of new technologies.

In Europe, the Middle East, and Africa, regional strategies are molded by varying regulatory environments and shifting consumer demands. The emphasis is on balancing cost-efficient solutions with state-of-the-art therapeutic approaches. Evolving animal health policies and increased awareness about sustainable livestock practices drive investment in innovative treatments across these regions. Meanwhile, in the Asia-Pacific region, accelerated economic growth combined with advancements in technology has spurred a dramatic increase in demand for modern livestock medicine. The region benefits from a blend of traditional practices and contemporary techniques, enhancing the overall quality of care delivered to diverse animal populations.

These nuanced insights into each region highlight the importance of localized strategies that not only address specific market requirements but also harness global trends to foster overall industry growth.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Company Insights Shaping the Industry Trends

Influential industry players continue to redefine the competitive landscape in livestock medicine through innovation and strategic collaborations. Market leaders such as Anicon Labor GmbH by SAN Group GmbH and AniCura Group by Mars Petcare have been at the forefront of developing cutting-edge therapeutic products and services. Companies like Biogenesis Bago SA and Boehringer Ingelheim International GmbH are setting new benchmarks with state-of-the-art research and development initiatives that pave the way for novel treatment protocols.

Similarly, Calier Laboratories S.A. and Ceva Sante Animale are noted for their impressive track records in developing agreed-upon standards that balance efficacy with safety. Dechra Pharmaceuticals PLC and Elanco Animal Health Inc. have significantly contributed to the evolution of product portfolios by addressing complex health issues with targeted therapies. Other prominent players including HESTER BIOSCIENCES LIMITED, HIPRA S.A., and Indian Immunologicals Ltd. have solidified their market positions through continuous innovation in both product development and market outreach.

In addition, industry giants such as Koninklijke DSM N.V., Merck KGaA, Neogen Corporation, Norbrook Laboratories Ltd., and Parnell Pharmaceuticals Holdings Ltd. are perceived as key drivers of transformation. Companies like Phibro Animal Health Corporation and Vetoquinol S.A. consistently innovate to improve product effectiveness while maintaining high safety standards. Vetpharma Animal Health S.L., Virbac SA, and Zoetis Inc. further underscore the commitment to quality, solidifying the collective impact of strategic initiatives that shape market trends and contribute significantly to overall industry growth.

The report delves into recent significant developments in the Livestock Medicine Market, highlighting leading vendors and their innovative profiles. These include Anicon Labor GmbH by SAN Group GmbH, AniCura Group by Mars Petcare, Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Calier Laboratories S.A., Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc., HESTER BIOSCIENCES LIMITED, HIPRA S.A., Indian Immunologicals Ltd., Koninklijke DSM N.V., Merck KGaA, Neogen Corporation, Norbrook Laboratories Ltd., Parnell Pharmaceuticals Holdings Ltd., Phibro Animal Health Corporation, Vetoquinol S.A., Vetpharma Animal Health S.L., Virbac SA, and Zoetis Inc..

Actionable Recommendations for Industry Leaders

In the face of rapid market evolution, industry leaders are encouraged to adopt a proactive approach that balances technological innovation with market responsiveness. It is essential to invest in research focused on next-generation therapeutics to improve the efficacy and safety of livestock treatments. Strategic partnerships should be fostered not only to accelerate product development but also to facilitate the adoption of digital solutions that enhance diagnostic precision and treatment customization.

Leaders are advised to implement robust data analytics frameworks that enable real-time tracking of market trends and treatment outcomes. This approach will help in tailoring strategies that resonate with diverse market segments across product types, disease profiles, and animal categories. Furthermore, the incorporation of advanced biosecurity measures and refined supply chain management techniques can mitigate risks and ensure operational continuity.

Emphasizing sustainable practices and streamlining regulatory processes are also crucial. By actively engaging with policymakers and industry consortia, decision-makers can help shape an ecosystem that fosters innovation while ensuring compliance. These recommendations are designed to drive competitive advantage, stimulate growth, and position organizations to effectively navigate the complexities of an evolving industry landscape.

Embracing Change and Innovation in Livestock Medicine

The comprehensive analysis provided in this report underscores the critical transformations shaping livestock medicine. By delving into transformative shifts, segmentations, regional dynamics, and the driving influence of leading companies, it becomes evident that the industry is poised for robust growth fueled by continuous innovation. The interplay between cutting-edge science, strategic market positioning, and evolving consumer expectations is creating a fertile ground for advancement.

In light of these developments, stakeholders are reminded of the importance of staying agile and responsive in an ever-changing environment. The convergence of modern diagnostics, advanced therapeutic agents, and comprehensive market segmentation provides a foundation for not only addressing prevailing challenges but also exploiting emerging opportunities. As the industry advances, collaboration, strategic foresight, and a commitment to excellence will remain the cornerstones of success. Embracing these elements will empower industry participants to drive progress, ensure competitive advantage, and ultimately secure a sustainable future in livestock medicine.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased government regulations and initiatives to ensure animal welfare and minimize disease spread
5.1.1.2. Growing awareness among livestock farmers about the benefits of preventive healthcare measures
5.1.1.3. Rising prevalence of livestock diseases boosting investments in veterinary pharmaceuticals
5.1.2. Restraints
5.1.2.1. Limited research funding and innovation slowing down the development of next-generation livestock drugs
5.1.3. Opportunities
5.1.3.1. Expansion of antibiotic alternatives in livestock production in response to regulatory changes
5.1.3.2. Collaboration with biotech firms to innovate groundbreaking vaccines for emerging livestock diseases
5.1.4. Challenges
5.1.4.1. Risks of disease outbreaks and biosecurity in the livestock industry
5.2. Market Segmentation Analysis
5.2.1. Product Type : Growing significance of antibiotics in preventing and managing bacterial infections among livestock populations
5.2.2. End Users: Rising role of veterinary hospitals in the implementation of precision medicine for livestock
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Livestock Medicine Market, by Product Type
6.1. Introduction
6.2. Anti-inflammatory Agents
6.3. Antibiotics
6.3.1. Cephalosporins
6.3.2. Penicillins
6.3.3. Tetracyclines
6.4. Antiparasitic Agents
6.4.1. Ectoparasiticides
6.4.2. Endoparasiticides
6.5. Feed Additives
6.5.1. Prebiotics
6.5.2. Probiotics
6.6. Hormones
6.6.1. Growth Hormones
6.6.2. Reproductive Hormones
6.7. Vaccines
6.7.1. Inactivated Vaccines
6.7.2. Live Attenuated Vaccines
6.7.3. Subunit Vaccines
7. Livestock Medicine Market, by Disease Type
7.1. Introduction
7.2. Infectious Diseases
7.3. Metabolic Diseases
7.4. Nutritional Deficiency Diseases
7.5. Parasitic Diseases
7.6. Reproductive Diseases
8. Livestock Medicine Market, by Animal Type
8.1. Introduction
8.2. Aquaculture
8.3. Cattle
8.4. Goats
8.5. Poultry
8.6. Sheep
8.7. Swine
9. Livestock Medicine Market, by Formulation
9.1. Introduction
9.2. Capsules
9.3. Gels
9.4. Liquids
9.5. Powders
9.6. Tablets
10. Livestock Medicine Market, by Route of Administration
10.1. Introduction
10.2. Inhalation
10.3. Injectable
10.3.1. Intramuscular
10.3.2. Intravenous
10.4. Oral
10.4.1. Liquids
10.4.2. Tablets
10.5. Topical
10.5.1. Creams
10.5.2. Patches
11. Livestock Medicine Market, by End Users
11.1. Introduction
11.2. Livestock Farmers
11.3. Veterinary Clinics
11.4. Veterinary Hospitals
12. Americas Livestock Medicine Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Livestock Medicine Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Livestock Medicine Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Scenario Analysis
15.3.1. Phibro Animal Health Corporation completes acquisition of Zoetis’ medicated feed additive product portfolio
15.3.2. Fischer MV partners with BAV to launch advanced vaccines in India
15.3.3. Virbac's strategic acquisition of Sasaeah strengthens its position in Japan's livestock vaccine market
15.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. LIVESTOCK MEDICINE MARKET MULTI-CURRENCY
FIGURE 2. LIVESTOCK MEDICINE MARKET MULTI-LANGUAGE
FIGURE 3. LIVESTOCK MEDICINE MARKET RESEARCH PROCESS
FIGURE 4. LIVESTOCK MEDICINE MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 9. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 11. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 13. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 15. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 17. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 19. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 21. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 23. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 25. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 28. LIVESTOCK MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 29. LIVESTOCK MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. LIVESTOCK MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. LIVESTOCK MEDICINE MARKET DYNAMICS
TABLE 7. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY GROWTH HORMONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REPRODUCTIVE HORMONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY NUTRITIONAL DEFICIENCY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PARASITIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REPRODUCTIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY GOATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY SHEEP, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK FARMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 111. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 113. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 114. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 115. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 116. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 117. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 118. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 119. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 120. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 122. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 123. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 124. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 125. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 127. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 128. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 129. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 130. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 131. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 132. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 133. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 134. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 136. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 137. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 138. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 154. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 156. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 158. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 160. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 169. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 171. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 172. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 173. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 174. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 175. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 176. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 177. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 178. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 180. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 183. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 185. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 186. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 187. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 188. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 189. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 190. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 191. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 192. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 193. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 194. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 195. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 196. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 197. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 199. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 200. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 201. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 202. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 203. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 204. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 205. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 206. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 208. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 209. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 210. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 211. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 213. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 214. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 215. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 216. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 217. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 218. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 219. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 220. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 221. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 222. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 223. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 224. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 225. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 227. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 228. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 229. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 230. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 231. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 232. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 233. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 234. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 235. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 236. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 237. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 238. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 239. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 241. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 242. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 243. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 244. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 245. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 246. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 247. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 248. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 249. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 250. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 251. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 252. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 253. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 256. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 257. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 258. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 259. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 260. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 261. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 262. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 263. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 264. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 265. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 266. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 267. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 269. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 270. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 271. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 272. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 273. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 274. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 275. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 276. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 277. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 278. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 279. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 280. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 281. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 283. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 284. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 285. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 286. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 287. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 288. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 289. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 290. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 291. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 292. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 293. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 294. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 295. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 296. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 297. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 298. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 299. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 300. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 301. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 302. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 303. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 304. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 305. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 306. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 307. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 308. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 309. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 311. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 312. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 313. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 314. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 315. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 316. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 317. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 318. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 319. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 320. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 321. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 322. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 323. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 324. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 325. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 326. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 327. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 328. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 329. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 330. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 331. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 332. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 333. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 334. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 335. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 336. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 337. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 338. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 339. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 341. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 342. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 343. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 344. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 345. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 346. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 347. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 348. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 349. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 350. EUROPE, MIDDLE EAST & AFRICA LIVE

Companies Mentioned

  • Anicon Labor GmbH by SAN Group GmbH
  • AniCura Group by Mars Petcare
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Calier Laboratories S.A.
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Inc.
  • HESTER BIOSCIENCES LIMITED
  • HIPRA S.A.
  • Indian Immunologicals Ltd.
  • Koninklijke DSM N.V.
  • Merck KGaA
  • Neogen Corporation
  • Norbrook Laboratories Ltd.
  • Parnell Pharmaceuticals Holdings Ltd.
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • Vetpharma Animal Health S.L.
  • Virbac SA
  • Zoetis Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages195
PublishedMarch 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 20.56 Billion
Forecasted Market Value ( USD ) by 2030 $ 26.63 Billion
Compound Annual Growth Rate5.2%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Livestock Insurance Global Market Report 2024 - Product Image

Livestock Insurance Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Asia-Pacific Livestock Insurance Market, By Country, Competition, Forecast & Opportunities, 2020-2030F - Product Image

Asia-Pacific Livestock Insurance Market, By Country, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • 132 Pages
  • Asia Pacific
From
Farm Animal Pain Relief and Prevention Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Farm Animal Pain Relief and Prevention Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 186 Pages
  • Global
From
Veterinary Pharmaceuticals Market by Products (Drugs, Medicinal Feed, Vaccines), Animal Type (Companion Animals, Livestock Animals), Mode of Administration, Indications, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Veterinary Pharmaceuticals Market by Products (Drugs, Medicinal Feed, Vaccines), Animal Type (Companion Animals, Livestock Animals), Mode of Administration, Indications, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Febantel Market by Application (Antiparasitic Treatments, Veterinary Medicine), Industry Use (Animal Healthcare, Livestock Management), Formulation Type, Distribution Channel, End-user - Global Forecast 2025-2030 - Product Image

Febantel Market by Application (Antiparasitic Treatments, Veterinary Medicine), Industry Use (Animal Healthcare, Livestock Management), Formulation Type, Distribution Channel, End-user - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.